PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study links caffeinated coffee to vision loss

2012-10-04
(Press-News.org) Rockville, MD – A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.

The study, The Relation between Caffeine and Coffee Consumption and Exfoliation Glaucoma or Glaucoma Suspect: A Prospective Study in Two Cohorts, is the first to examine the link between caffeinated coffee and exfoliation glaucoma in a U.S. –based population.

"Scandinavian populations have the highest frequencies of exfoliation syndrome and glaucoma," said author, Jae Hee Kang, ScD, of Channing Division of Network Medicine at Brigham and Women's Hospital in Boston, Mass. "Because Scandinavian populations also have the highest consumption of caffeinated coffee in the world, and our research group has previously found that greater caffeinated coffee intake was associated with increased risk of primary open-angle glaucoma, we conducted this study to evaluate whether the risk of exfoliation glaucoma or glaucoma suspect may be different by coffee consumption."

The study was composed of two cohorts: 78,977 women from the Nurses' Health Study (NHS) and 41,202 men from the Health Professionals Follow-up Study (HPFS) who were at least 40 years of age, did not have glaucoma and reported undergoing eye examinations from 1980 (for NHS participants) and 1986 (for HPFS participants) to 2008. The research team used questionnaires to obtain and validate the consumption of beverages containing caffeine and reviewed medical records to determine incident cases of exfoliation glaucoma, which contributes to elevated pressure sufficient enough to damage the optic nerve, or exfoliation glaucoma suspect that have milder or only suspect optic nerve damage.

A meta-analysis of the two cohorts showed that, compared to abstainers, participants who drank three cups or more of caffeinated coffee daily were at an increased risk of developing exfoliation glaucoma or glaucoma suspect. The researchers did not find associations with consumption of other caffeinated products, such as soda, tea, chocolate or decaffeinated coffee. The results also showed that women with a family history of glaucoma were at an increased risk.

Kang, along with his colleagues, report that this study represents a much needed effort to better understand the causes of exfoliation glaucoma, which are largely unknown.

"Because this is the first study to evaluate the association between caffeinated coffee and exfoliation glaucoma in a U.S. population, confirmation of these results in other populations would be needed to lend more credence to the possibility that caffeinated coffee might be a modifiable risk factor for glaucoma," said Kang. "It may also lead to research into other dietary or lifestyle factors as risk factors.

### The ARVO peer-reviewed journal Investigative Ophthalmology & Visual Science (IOVS) publishes results from original hypothesis-based clinical and laboratory research studies, as well as Reviews, Perspectives, and Special Issues. IOVS 2009 Impact Factor ranks No. 4 out of 45 among ophthalmology journals. The journal is online-only and articles are published daily.

The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 13,000 eye and vision researchers from over 80 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.

Visit us at:

Website: www.arvo.org Twitter: www.twitter.com/ARVOinfo Facebook: www.facebook.com/ARVOinfo Flicker: www.flickr.com/photos/ARVOinfo YouTube: www.youtube.com/user/ARVOinfo


ELSE PRESS RELEASES FROM THIS DATE:

OU researchers implement a multi-photon approach in quantum cryptography

2012-10-04
NORMAN, Okla. – Move over money, a new currency is helping make the world go round. As increasing volumes of data become accessible, transferable and, therefore, actionable, information is the treasure companies want to amass. To protect this wealth, organizations use cryptography, or coded messages, to secure information from "technology robbers." This group of hackers and malware creators increasingly is becoming more sophisticated at breaking encrypted information, leaving everyone and everything, including national security and global commerce, at risk. But the threat ...

Anthropologist finds evidence of hominin meat eating 1.5 million years ago

2012-10-04
DENVER (Oct. 4, 2012) – A skull fragment unearthed by anthropologists in Tanzania shows that our ancient ancestors were eating meat at least 1.5 million years ago, shedding new light into the evolution of human physiology and brain development. "Meat eating has always been considered one of the things that made us human, with the protein contributing to the growth of our brains," said Charles Musiba, Ph.D., associate professor of anthropology at the University of Colorado Denver, who helped make the discovery. "Our work shows that 1.5 million years ago we were not opportunistic ...

'Humanized' mice advance study of rheumatoid arthritis

2012-10-04
Researchers at Northwestern University Feinberg School of Medicine have developed the first animal model that duplicates the human response in rheumatoid arthritis (RA), an important step that may enable scientists to discover better medicines to treat the disease. Corresponding and senior author Harris Perlman, associate professor of rheumatology at Feinberg, introduced his team's new prototype mouse model in a recent online issue of the Journal of Translational Medicine. "This is the first time human stem cells have been transplanted into mice in order to find RA ...

Progress reported in tackling initial, recurrent bouts of health care-associated infection

2012-10-04
CHICAGO — Surgeons are making progress toward preventing initial and recurrent episodes of clostridium difficile colitis (C. difficile or C. diff), a vicious bacterial infection that is estimated to affect about 336,000 people each year, typically patients on antibiotics. Using mouse models, researchers at the Massachusetts General Hospital (MGH), Boston, found that an oral medication may prevent C. difficile infections (CDI). Also, surgeons at Penn State University College of Medicine, Hershey, PA, examined human patients to detect a genetic mutation that could steer ...

New human neurons from adult cells right there in the brain

2012-10-04
VIDEO: This is a direct observation of neuronal reprogramming of PDGFR-sorted pericyte-derived cells from the adult human brain by continuous live imaging in culture. Note the change in morphology of a cell... Click here for more information. Researchers have discovered a way to generate new human neurons from another type of adult cell found in our brains. The discovery, reported in the October 5th issue of Cell Stem Cell, a Cell Press publication, is one step toward cell-based ...

Newborn mice depend on mom's signature scent

2012-10-04
VIDEO: For newborn mice to suckle for the very first time and survive, they depend on a signature blend of scents that is unique to their mothers. The findings, published online... Click here for more information. For newborn mice to suckle for the very first time and survive, they depend on a signature blend of scents that is unique to their mothers. The findings, published online on October 4 in Current Biology, a Cell Press publication, reveal that mom's natural perfume consists ...

Botox as effective as medication for urinary urgency incontinence

2012-10-04
MAYWOOD – Botox® (onabotulinum toxin-A) injections to the bladder are as effective as medication for treating urinary urgency incontinence in women, but the injection is twice as likely to completely resolve symptoms. These findings were published in the latest issue of The New England Journal of Medicine by a National Institutes of Health clinical trials network including Loyola University Chicago Stritch School of Medicine (SSOM). Urgency incontinence is urinary incontinence with a strong or sudden need to urinate. Traditionally, this condition has been treated with ...

Clot-busting enzymes are working 2 jobs

2012-10-04
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma. In research published today in Cell Reports, scientists from Monash University have demonstrated for the first time the enzyme t-PA, which plays a vital role in the removal of blood clots, is also a major player in the removal of necrotic, or dead, cells. Necrosis occurs when cells in living tissue die prematurely due to external stress or injury. The body's system for removing waste ...

The smell of Mom: Scientists find elusive trigger of first suckling in mice

The smell of Mom: Scientists find elusive trigger of first suckling in mice
2012-10-04
LA JOLLA, CA – A team led by biologists at The Scripps Research Institute has solved the long-standing scientific mystery of how mice first know to nurse or suckle. This basic mammalian instinct, which could be a key to understanding instinctive behavior more generally, was thought to be triggered by a specific odor (pheromone) that all mouse mothers emit. But, as described online ahead of print by the journal Current Biology on October 4, 2012, the trigger in mice turns out to be a more complicated blend of nature and nurture: a signature mix of odors, unique for each ...

In cancer, an embryonic gene-silencing mechanism gone awry

2012-10-04
There are some genes that are only activated in the very first days of an embryo's existence. Once they have accomplished their task, they are shut down forever, unlike most of our genes, which remain active throughout our lives. EPFL scientists have unveiled part of this strange mechanism. The same process, accidentally initiated later in life, could be responsible for many kinds of cancer. The discovery is described in a recent article in the journal Cell Reports. The researchers identified a group of proteins that play a key role in this phenomenon. They bind to a ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] New study links caffeinated coffee to vision loss